MYX mayne pharma group limited

CDMO revenues increased >50% on FY22 largely attributable to new...

  1. 1,070 Posts.
    lightbulb Created with Sketch. 92
    CDMO revenues increased >50% on FY22 largely attributable to new third
    party contract sales in 2H following divestment of US Retail Generics

    12m investment in partnership with the Australian Government who
    provided an $4.8m grant under their Modern Manufacturing Initiative
    (MMI) program improves capabilities and efficiencies in the Salisbury
    facility
    ● CDMO revenues increased >50% on FY22 largely attributable to new third
    party contract sales in 2H following divestment of US Retail Generics
    ● MPA revenues increased 7% on FY22 with in licensed product growth of
    26% attributable to new product launches and growth in existing product
    portfolio
    https://hotcopper.com.au/data/attachments/5558/5558344-26d253c496d28182e448674a193ba722.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.99
Change
-0.090(1.77%)
Mkt cap ! $405.4M
Open High Low Value Volume
$5.05 $5.05 $4.99 $1.254M 250.3K

Buyers (Bids)

No. Vol. Price($)
4 22359 $4.98
 

Sellers (Offers)

Price($) Vol. No.
$5.08 2631 2
View Market Depth
Last trade - 16.11pm 08/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.